We develop and produce highly specialized targeted investor and business development conferences exclusively for the biopharmaceutical and life sciences industries.
With over 20 years’ experience connecting leaders of innovative biotech companies with key stakeholders, investors and advisors, we create ideal environments to examine and address opportunities and challenges in today’s biotech industry.
Sara Jane Demy, CEO, Demy-Colton, introducing a fireside chat in July, 2018
Discussion leaders from an array of disciplines facilitate the conversations which range from high-level problems shared with the group to specific issues that arise during organizational growth, such as going through an IPO or dealing with a clinical trial failure.
NEW YORK & SAN FRANCISCO & CARLSBAD, Calif.--(BUSINESS WIRE)--Biotech Showcase™, one of the most influential international biotechnology investor conferences in the world, concluded in San Francisco the second week of January and brought together more than 3,600 decision makers and biotech investors shaping the biopharmaceutical industry.